India’s Race to Manufacture Affordable Obesity Drugs Amid Ozempic’s Market Entry

Industries

India’s obesity-drug market is transforming as semaglutide goes off patent, driving Ozempic's generic manufacturing, price shifts, and new opportunities in GLP-1 therapies.

Industries

New Drug Manufacturing Rules 2026: India's 3-Tier Change Classification & DCGI Licensing Overhaul

Navigate the 2026 drug manufacturing reforms: a guide to India's mandatory pharma change reporting, 3-tier risk classifications, and standardized Drugs Controller General of India (DCGI) licensing norms.

Industries

Eli Lilly’s Mounjaro Tops India’s Drug Sales – What It Reveals About the Country’s Health Market

Eli Lilly’s Mounjaro tops India’s drug sales, signaling a healthcare pivot toward obesity and diabetes management. See how it’s reshaping India’s pharma market.

Legal & Regulatory

Protecting Your Brand in India: Trademark Registration and IP Strategy for Foreign Businesses

Learn how foreign companies can protect their brand in India through trademark registration, IP strategy, and enforcement mechanisms in one of the world’s fastest-growing consumer markets.

Get free access to our subscriptions and publications

Subscribe to receive weekly India Briefing news updates, our latest doing business publications, and access to our Asia archives.

Sign Up Now
India Briefing

Economy & Trade

Economy & Trade

How to Import Restricted Goods in India: DGFT License Process, Documents & Compliance Guide

Mar 20

Following the DGFT’s March 16 notification, certain key commodities have transitioned from "free" to "restricted" status till June 30, 2026. Learn the essential authorization process and documentation required to mitigate any import regulatory risk.

 

Tax & Accounting

Tax & Accounting

India’s Modern Gratuity Regime: Calculation, Taxation, and Statutory Compliance

Mar 23

Understand gratuity in India for FY 2026–27, including eligibility, calculation under the Code on Wages, and tax treatment under the Income-tax Act, 2025 and Rules, 2026, with exemptions and relief provisions.

 

Legal & Regulatory

Legal & Regulatory

Corporate Laws (Amendment) Bill, 2026: 10 Things Businesses Need to Know

Mar 25

Explore 10 key highlights of India’s Corporate Laws (Amendment) Bill, 2026, including IFSC reforms, CSR changes, audit rules, and compliance updates.

Industries

Industries

India’s Race to Manufacture Affordable Obesity Drugs Amid Ozempic’s Market Entry

Mar 24

India’s obesity-drug market is transforming as semaglutide goes off patent, driving Ozempic's generic manufacturing, price shifts, and new opportunities in GLP-1 therapies.

 

HR & Payroll

HR & Payroll

Employee Termination in India: Settlement Timelines, Retrenchment Rules, and Employer Compliance

Mar 24

A strategic advisor’s guide to employee termination in India under the 2026 Industrial Relations Code. Navigate revised retrenchment protocols, mandatory 48-hour full and final settlements, and critical compliance mandates for modern enterprises.

 

Expert Guidance about Business in Asia

Dezan Shira & Associates is a pan-Asia, multi-disciplinary professional services firm, providing market entry, legal, accounting, tax, HR, technology and operational advisory to international investors.

Business Updates for All Asia Markets

Asia Briefing publishes articles, magazines, and guides on doing business in Asia. Dezan Shira & Associates has produced the publication since 1999.

About Asia Briefing Ask Us a Question

Need More Guidance?

India Briefing Publications

Download magazines and guides on doing business in India.

Download Now
Back to top